LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 1694 | 4177 | 11155 | 0.3745 | 0.2624 |
MCF 10A | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10578 | 11155 | 0.9483 | 0.9390 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10910 | 11155 | 0.9780 | 0.9741 |
MCF 10A | XL147 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10465 | 11155 | 0.9381 | 0.9270 |
MCF 10A | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 10020 | 11155 | 0.8982 | 0.8800 |
MCF 10A | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 3915 | 11155 | 0.3510 | 0.2348 |
MCF 10A | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1694 | 12534 | 11155 | 1.1236 | 1.1457 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11440 | 11155 | 1.0255 | 1.0301 |
MCF 10A | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10329 | 11155 | 0.9259 | 0.9126 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10354 | 11155 | 0.9282 | 0.9153 |
MCF 10A | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10872 | 11155 | 0.9746 | 0.9701 |
MCF 10A | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 2899 | 11155 | 0.2599 | 0.1274 |
MCF 10A | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 2038 | 11155 | 0.1827 | 0.0364 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 2067 | 11155 | 0.1854 | 0.0395 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 3044 | 11155 | 0.2729 | 0.1427 |
MCF 10A | TWS119 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 11511 | 11155 | 1.0319 | 1.0376 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10972 | 11155 | 0.9836 | 0.9807 |
MCF 10A | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 1694 | 9899 | 11155 | 0.8874 | 0.8672 |
MCF 10A | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 1694 | 9848 | 11155 | 0.8828 | 0.8618 |
MCF 10A | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 3270 | 11155 | 0.2931 | 0.1665 |
MCF 10A | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 916 | 11155 | 0.0821 | -0.0823 |
MCF 10A | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 9518 | 11155 | 0.8533 | 0.8270 |
MCF 10A | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 9405 | 11155 | 0.8431 | 0.8150 |
MCF 10A | YM 201636 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10243 | 11155 | 0.9183 | 0.9036 |
MCF 10A | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 8257 | 11155 | 0.7402 | 0.6937 |